World Diabetes Day, 14 November How Organisations Can Support Mobile Workforces with Diabetes – From Prevention to Management

LONDON, UK, 7th November 2024 – As global mobility surges, managing chronic conditions like diabetes during travel has…

Semaglutide significantly reduces risk of major kidney disease events, cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease, groundbreaking study reveals

A pioneering study has demonstrated that semaglutide significantly reduces the risk of major kidney disease events,…

App’s new module gives people with diabetes vital extra support with foot care

A new high-tech aid to help people with diabetes keep their feet healthy has been launched…

New research reveals digital plans of care improve health outcomes for type 2 diabetes patients

Research conducted as part of UKRIs digital health technology catalyst sponsored by Healum Ltd in partnership…

NHS set to save millions thanks to MedTech startup opening funding round

Fyous, a MedTech startup, open third funding round. Reaching a £10m valuation in just over two…

New Fluorescent Chiral-Selective Receptor System Represents a Breakthrough in Molecular Detection with Potential for Applications in Diabetes Management

Cyclodextrin and monoboronic acid-based receptor complexes show excellent D-glucose chiral selectivity ,paving the way for improved…

Sigrid Therapeutics demonstrates that their novel diabetes and obesity silica device functions during the digestive process in humans

Swedish company Sigrid Therapeutics is delighted to announce its latest results which back the use of…

Study: Text message prompts to patients increase referrals to NHS Diabetes Prevention Programme by 1000%+

A pilot study of 795 pre-diabetic patients has shown the significant potential of ICB-managed text messaging…

Adoption of sight-saving sleep mask could save the NHS millions

A pioneering treatment to prevent blindness in people suffering from diabetic retinopathy is set to benefit…

Dexcom G7 Launches in the UK

DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes,…